IMMUNOVO
Immunovo BV is a Dutch private biotechnology company, based in ‘s-Hertogenbosch, engaged in the discovery and clinical development of immunotherapeutics in the field of oncology. The key priority for Immunovo is on its proprietary Immune Activation System (IAS) based on combining synthetic peptide antigens with a novel immune stimulant (adjuvant).
IMMUNOVO
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
's-hertogenbosch, Noord-Brabant, The Netherlands
Country:
The Netherlands
Website Url:
http://www.immunovo.com
Total Employee:
1+
Status:
Active
Contact:
+31 (0) 73 – 627 4520
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Facebook Sharer OpenResty AdBlock Acceptable Ads Sharktech Shark Tech
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Employees Featured
Wim Mol Board of Directors @ Immunovo
Board of Directors
Evert Jan Schenkelaars Chief Medical Officer @ Immunovo
Chief Medical Officer
Investors List
Biox Biosciences
Biox Biosciences investment in Seed Round - Immunovo
Lupus Ventures
Lupus Ventures investment in Seed Round - Immunovo
More informations about "Immunovo"
Immunovo Company Profile - Craft
Immunovo is a biotechnology company engaged in the discovery and clinical development of immunotherapeutics in the field of oncology. It offers the Immune Activation System (IAS) …See details»
Immunovo - Products, Competitors, Financials, Employees, …
Developer of methods in immunotherapy with insights in oncology. Use the CB Insights Platform to explore Immunovo's full profile.See details»
Immunovo - Overview, News & Similar companies | ZoomInfo.com
View Immunovo (www.immunovo.com) location in North Brabant, Netherlands , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Immunovo - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 28, 2010: Seed Round - …See details»
Immunovo - VentureRadar
Immunovo VentureRadar profile. Find out more about Immunovo, Vaccines.See details»
Immunovo - Crunchbase
Immunovo is operate as a biotechnology company to develop technology to create immunotherapeutic drugsSee details»
Immunovo BV:Company Profile & Technical Research,Competitor …
Discovery Company profile page for Immunovo BV including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Immunovo - Company Profile - Tracxn
Immunovo - Mid-stage, Dutch private biotechnology company focusing on discovery and clinical development of immunotherapeutics in Oncology.. This company is not active anymore. …See details»
Immunovo B.V. - BioCentury Company Profiles - BCIQ
Jan 17, 2011 Immunovo B.V. - BioCentury Company Profiles for the biopharma industrySee details»
New Biotechnology Company: Immunovo BV - Immunovo BV …
Apr 29, 2010 Immunovo BV, a new biotechnology company developing a novel technology platform for the creation of a new generation of immunotherapeutics, has secured seed …See details»
ImmuNovX Biotech
ImmuNovX Biotech is an early-stage company whose mission is to develop the groundbreaking technology . we call LR3N-CS, a platform that allows rapid, large-scale treatment of DNA …See details»
Immunovo BV- A New Biotechnology Company is Announced
Apr 28, 2010 S-HERTOGENBOSCH, The Netherlands, April 27, 2010 /PRNewswire/ -- Immunovo BV, a new biotechnology company looking to combine novel methods in …See details»
Immunova Company Profile - Office Locations, Competitors ... - Craft
See insights on Immunova including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Imuno Company Profile 2024: Valuation, Funding & Investors
Imuno General Information Description. Developer of a discovery engine designed to identify cancer-specific epitopes. The company's structure-based therapy platform visualizes the …See details»
Immunovo BV- A New Biotechnology Company is Announced - PR …
Apr 27, 2010 S-HERTOGENBOSCH, The Netherlands, April 27, 2010 /PRNewswire/ -- Immunovo BV, a new biotechnology company looking to combine novel methods in …See details»
ImmuNovX Biotech | Life Sciences PA
ImmuNovX Biotech is an early-stage company whose mission is to develop the groundbreaking technology we call LR3N-CS, a platform that allows rapid, large-scale treatment of DNA …See details»
ImmuNovo will make a major contribution to in-depth research …
Prof. Dr. Bob Pinedo MD PhD is linked to ImmuNovo as a Senior Medical and Scientific Advisor. Being a acknowledged oncologist Mr Pinedo has confidence in the future of immunotherapy …See details»
ImmuNovX Biotech - PitchBook
ImmuNovX Biotech is headquartered in Conshohocken, PA. What industry is ImmuNovX Biotech in? ImmuNovX Biotech’s primary industry is Drug Discovery. Is ImmuNovX Biotech a private or …See details»
Ben Franklin Technology Partners Announces $1.1 Million In Q2 ...
Jan 10, 2025 Learn more at immunovx.com. Ilico Genetics, Northampton County. Ilico is developing a groundbreaking early screening test for stomach cancer using blood samples. …See details»